Press Releases

Press Releases

Antimicrobial resistance in India threatens the survival of newborns

September 21, 2016

Multicenter study of neonatal sepsis and resistance in India underscores the need for greater attention and prevention strategies

In a large multi-center study of neonatal sepsis in tertiary care hospitals in India, sepsis incidence and mortality was high and antimicrobial resistance increased the case fatality rates. Overall, nearly one-quarter of the neonatal deaths were from sepsis. The results, published in The Lancet, indicate the need to understand the pathogenesis of sepsis in newborns and infants, as well as the need to implement proven infection control interventions to prevent the illness in low-income and middle-income countries.

Alliance to support UN resolution against antimicrobial resistance formed by leading global health organizations

September 20, 2016

The Conscience of Antimicrobial Resistance Accountability (CARA) is an alliance to support the United Nations Resolution on Antimicrobial Resistance

WASHINGTON, D.C. - Nine founding organizations have launched CARA—the Conscience of Antimicrobial Resistance Accountability—an alliance formed in anticipation of the Resolution to be introduced at the UN General Assembly High-Level Meeting on Antimicrobial Resistance. More organizations from the public and private sectors around the world are expected to join in the coming months.

Fuel blockade in Nepal has earthquake-level health effects

September 19, 2016

After a devastating earthquake in April 2015, Nepal is set back by another disaster, a fuel blockade imposed by India for political leverage

A blockade imposed by India in fall 2015, in response to provisions of Nepal’s new constitution, led to a severe fuel crisis, which has caused devastating health consequences for the population of Nepal. BP Koirala Institute of Health Science Assistant Professor Shyam Sundar Budhathoki and CDDEP Associate Director for Policy Hellen Gelband comment on the blockade in BMJ Global Health.

$1.72 trillion in economic productivity has resulted from polio eradication efforts in India, nearly 400,000 deaths prevented

September 19, 2016

Three decades of polio eradication efforts in India has saved more than 390,000 lives, averted nearly 4 million cases of paralysis and boosted productivity by US$1.71 trillion

CDDEP-contributed research published in Indian Pediatrics has examined the health and economic benefits of three decades of polio eradication efforts in India, estimating that India has averted 3.94 million paralytic cases of polio, 393,918 related deaths, and 1.48 billion disability-adjusted life-years (DALYs). As a result of eradication efforts, India has also gained US$1.71 trillion in economic productivity between 1982 and 2012, according to the study’s base case analysis.

Improved sanitation and water access could prevent 77,000 childhood deaths each year in India, according to new CDDEP study

September 8, 2016

Improved sanitation and water access could prevent more than 50 million episodes of diarrheal disease and save more than $400 million in medical treatment expenditure each year.

India accounts for a fifth of the global deaths of children under the age of five years, topping the list of contributors to this burden. More than 300,000 under-five children in India die from diarrheal diseases each year, with an associated economic loss of (in 2013 US$) $13 billion, or 1.5 percent of gross domestic product.

First long-term, national-scale study of antibiotic resistance in India indicates urgent need for stewardship programs, new antibiotics

September 8, 2016

Results indicate urgent need for programs to maintain antibiotic effectiveness and new antibiotics to treat Gram-negative infections

In the first long-term, national-scale study on trends in antibiotic resistance in India, based on more than 18,000 isolates collected by a large private diagnostic laboratory network from 2008 through 2014, CDDEP and SRL researchers found high and increasing antibiotic resistance rates among both Gram- negative and Gram-positive organisms. The findings underscore the urgent need for effective antibiotic stewardship programs and the development of new antibiotics, particularly for Gram-negative infections.

Experts urge a defensive stance in efforts against antimicrobial resistance

September 8, 2016

The global population of antimicrobial-susceptible microbes is a shared resource that is falling victim to the tragedy of the commons

WASHINGTON, D.C. - In a Comment in Nature, CDDEP Director Ramanan Laxminarayan and other experts in antimicrobial resistance suggest that the United Nations should reframe global efforts against antimicrobial resistance by adopting a defensive stance. The suggested focus should be in building the resilience of society and maintaining diversity in the “global microbiome”—only a fraction of which causes human or animal disease. 

Experts propose approach to maintain antibiotic effectiveness before meeting of world leaders

August 29, 2016

Proposed measures address global health crisis using One Health approach

WASHINGTON, D.C. - In today’s issue of Science, experts address the global health crisis of antibiotic effectiveness by proposing new global targets for the use of antibiotics. This proposal precedes the United Nations High-Level Meeting on Antimicrobial Resistance, in which heads of state will directly address the issue of antibiotic effectiveness. Lead author and CDDEP Director Ramanan Laxminarayan and co-authors offer a framework of actionable measures to reach the proposed target for reduced antibiotics use, involving surveillance systems, global financing for action plans, and the establishment of a global architecture to ensure appropriate access to antibiotics.

Leading world experts call on UN to mobilize a comprehensive global action plan to widen access to effective antibiotics

July 14, 2016

WASHINGTON, D.C. - Today some of the world’s foremost experts on antibiotic resistance called on the United Nations General Assembly to decisively act to reduce the growing number of deaths due to limited access to effective antibiotics.  Writing in the Lancet, they call on those attending the upcoming High-Level Meeting of Heads of State in September in New York City to use the opportunity to create and implement a four-part global action plan, similar in scope and ambition to the plan created in 1996 to address the AIDS crisis.

CDDEP study in The Lancet finds improved access to antibiotics could reduce child pneumonia deaths by 75 percent in 101 countries

A new CDDEP study, the lead article in a Lancet series on antibiotic resistance and access, estimates that in 101 countries, improved access to antibiotics could avert the deaths of more than 75 percent of children under five caused by pneumonia alone each year, or approximately 455,000 lives saved. The article was based on new analyses by a team of researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) working with collaborators in the UK and South Africa.